Bloomsbury Publishing

Key Tensions & Management Questions

Cross-statement patterns requiring diligence, with residualised management questions. Each tension synthesises signals from multiple financial statement sections.

Tension 1 of 6

The May 2024 acquisition of Rowman & Littlefield's academic publishing business has materially reshaped the group's balance sheet: goodwill rose 60% year-on-year and intangibles increased by £28m, together adding roughly 15% to the prior-year asset base. The investing outflow of £64m — equivalent to 17.7% of revenue — was only partially covered by £21m of new debt issuance, leaving the financing mix of the remainder unresolved from the disclosed figures alone.

Return on equity, which peaked at 16.4% in FY2024, fell to 12.0% by FY2025 — a 4.4 percentage point compression in a single year. Whether this reflects the dilutive effect of the expanded asset base, the interest burden on new debt, integration drag, or some combination is not determinable from the available data.

The asset trajectory in the first full post-acquisition year adds a further unresolved element: acquired intangibles declined £10m against a reported D&A charge of only £3m, a gap that the disclosed figures do not explain. Goodwill meanwhile held broadly stable at £75m. With exceptional items present in two of the five years across the review period and the group's segmental structure reorganised during the same window, the organic contribution of the acquired business remains difficult to isolate.

▶

Evidence

▶

Competing interpretations

Diligence question

In FY2026, acquired intangibles declined by £10m against a reported D&A charge of £3m, leaving a £7m gap unexplained by the disclosed figures. Can management provide the full amortisation schedule for the intangible assets recognised on acquisition of the Rowman & Littlefield business — including any impairment assessments or accelerated write-offs — together with a fair-value allocation note confirming the composition and remaining useful lives of those assets as at the FY2026 year-end?

Tension 2 of 6

The OCF/NI ratio compressed sharply from 2.35× to 1.35× between FY2022 and FY2023 — a swing of 1.00× in a single year — which is analytically notable because a high ratio typically signals cash conversion strength, and a rapid compression of that magnitude warrants scrutiny of what changed on either side of the fraction. Over the broader FY2022–FY2026 window, OCF itself proved volatile, ranging across a peak-to-trough swing of 35.7%, with FY2023 marking the trough and FY2025 the peak.

Exceptional items appeared in 2 of the 5 years across the same period and have been classified as recurring in nature. Whether the ratio compression reflects movement in net income, in operating cash flow, or in both simultaneously is not resolved by the available data. What remains open is whether the pattern of exceptional items and the OCF/NI step-change are analytically connected, and whether the subsequent OCF recovery to its FY2025 peak represents a durable normalisation or a temporary reversal within a volatile series.

▶

Evidence

▶

Competing interpretations

Diligence question

Can management provide a bridge of the FY2023 OCF/NI ratio movement — which compressed from 2.35× to 1.35× versus FY2022 — decomposed between (a) the year-on-year change in net income, including any exceptional items recognised in FY2023, and (b) the year-on-year change in operating cash flow, with working capital movements itemised separately? Specifically, what were the absolute FY2023 net income and OCF figures, and which line items account for the trough in OCF across the FY2022–FY2026 range of 27.0–42.0?

Tension 3 of 6

Bloomsbury's working capital position shows pressure from both sides of the balance sheet simultaneously. DSO has remained above 90 days for five consecutive years (FY2022–FY2026), reaching a range of 94–135 days — a persistent elevation that sits well outside standard trade terms. Within that period, receivables grew 56.8% year-on-year from FY2023 to FY2024 against revenue growth of 29.9%, a divergence that exceeds the 1.5× threshold used to flag structural imbalance. Working capital outflow reached £19m in FY2024, equivalent to 5.5% of revenue.

At the same time, trade payables fell from £48m to £30m across FY2024–FY2026, compressing the offset that supplier credit would otherwise provide. Whether the receivables build reflects the structure of long-term rights and distribution arrangements — trade receivables principally comprise amounts due from distributors — or something else in the collection cycle is not resolved by the available data. What remains open is whether the payables decline is a deliberate treasury decision, a shift in supplier mix, or a response to changed terms, and whether the DSO range reflects a stable but elevated steady state or continued drift.

▶

Evidence

▶

Competing interpretations

Diligence question

What are the contractual payment terms with Bloomsbury's major distributors, and what proportion of the trade receivables balance at FY2024 year-end — when receivables grew 56.8% against revenue growth of 29.9% — was current versus overdue by more than 30, 60, and 90 days?

Tension 4 of 6

Total debt grew 259.6% between FY2024 and FY2025, coinciding with the May 2024 acquisition of the Rowman & Littlefield academic publishing business, while cash fell 37.9% over the same period. The current ratio has declined across two consecutive years, moving from 1.81x to 1.62x between FY2023 and FY2025, compressing the short-term liquidity buffer as the balance sheet absorbed the step-up in obligations.

Interest expense then grew 133.3% in the following year (FY2025 to FY2026), and cash interest paid and income statement interest expense diverged by more than five times in FY2025 — a gap that makes it difficult to assess the true cash servicing burden from reported earnings alone. The Group held £14.8m in non-current borrowings under a Lloyds Bank facility at February 2026 and was in compliance with its interest cover and net debt-to-EBITDA covenants at that date, though quarterly covenant tests continue.

What remains unresolved is whether the divergence between cash and income-statement interest coverage reflects timing differences, capitalised costs, or something else — and how much further headroom exists against covenant thresholds as interest costs remain elevated.

▶

Evidence

▶

Competing interpretations

Diligence question

In FY2025, cash interest paid and income statement interest expense diverged by more than five times: what is the breakdown of that difference between timing/accrual items, capitalised financing costs, and any other components, and what were the specific covenant threshold levels (interest cover ratio and net debt-to-EBITDA) together with the headroom margin recorded at each quarterly test date through to the February 2026 compliance confirmation?

Tension 5 of 6

The aggregate pressure on operating cash flow has intensified markedly. In FY2022, four concurrent capital allocation claims — dividends, net equity outflows, debt repayment, and investing outflows — consumed 114% of OCF. By FY2025, three remaining claims had expanded to 189% of OCF, meaning the company was funding a growing shortfall from sources outside operating cash generation. Over the same window, total debt grew 259.6% between FY2024 and FY2025, while cash fell 37.9% year-on-year — the acquisition of the Rowman & Littlefield academic publishing business in May 2024 is the named transaction in this period.

Against this backdrop, net equity outflows have been small but unbroken across five consecutive years, ranging from £1m to £4m annually. Whether these outflows represent buybacks, distributions, or other equity movements, their persistence alongside rising debt and compressed cash raises a question the data does not resolve: whether the capital structure is being actively managed toward a target, or whether competing claims are simply outrunning the cash available to meet them.

▶

Evidence

▶

Competing interpretations

Diligence question

Given that capital allocation claims reached 189% of OCF in FY2025 — following total debt growth of 259.6% between FY2024 and FY2025 — does the company operate under a board-approved leverage target or post-acquisition deleveraging schedule, and do the sustained net equity outflows of £3m–£4m per annum in FY2024–FY2026 reflect a formally authorised return programme, or are these outflows determined on an ad hoc basis?

Tension 6 of 6

SG&A as a proportion of revenue has risen from 42.2% to 46.6% over FY2022–FY2026, a 446 basis point expansion that leaves FY2026 as the series high across the full five-year window. The scale and persistence of that drift is notable: it is not a single-year step but an endpoint-to-endpoint move across the entire observed period.

Against that backdrop, return on equity peaked at 16.4% in FY2024 and had fallen to 12.0% by FY2025 — a 4.4 percentage point compression in a single year. What remains unresolved is whether the SG&A expansion and the ROE compression are drawing on the same underlying dynamic or represent distinct pressures arriving simultaneously. The absence of a disclosed relationship between the two signals means the degree to which cost structure is the operative factor in the returns deterioration cannot be determined from the available data alone.

▶

Evidence

▶

Competing interpretations

Diligence question

What was the composition of the 4.4 percentage point ROE compression between FY2024 and FY2025 — specifically, what were the respective contributions of net income margin change, revenue growth, and equity base movement to that decline — and how does management reconcile those drivers with the 446 basis point expansion in SG&A as a percentage of revenue observed across FY2022–FY2026?

Metric	2022	2023	2024	2025	2026	Direction
Revenue (GBPm)	230	264	343	361	326	↑ trend
Gross profit (GBPm)	122	145	195	204	192	↑ trend
Operating income (GBPm)	23	26	41	33	35	↑ trend
EBITDA (GBPm)	25	29	44	36	38	↑ trend
Net income (reported) (GBPm)	17	20	32	25	27	↑ trend
Gross margin (%)	53.0	54.9	56.9	56.5	58.9	↑ trend
Operating margin (%)	10.0	9.8	11.9	9.1	10.7	flat
Net margin (reported) (%)	7.4	7.6	9.3	6.9	8.3	flat
Net margin (normalised) (%)	7.8	8.0	9.9	7.2	8.6	flat
Reported vs normalised (%)	-0.4	-0.4	-0.6	-0.3	-0.3	flat
SG&A as % revenue (%)	42.2	44.3	43.7	46.0	46.6	↑ trend
Capex as % revenue (%)	3.5	2.5	1.7	1.7	2.7	flat
OCF (GBPm)	40	27	38	42	41	↑ trend
FCF (GBPm)	32	20	32	36	32	flat
Capex (GBPm)	8	7	6	6	9	↑ trend
Dividends paid (GBPm)	15	9	11	12	13	↓ trend
Net cash / (debt) (GBPm)	29	41	57	9	14	↓ trend
Total debt (GBPm)	12	11	9	32	30	↑ trend
Current ratio (×)	1.7×	1.8×	1.7×	1.6×	1.8×	↑ trend
Interest coverage (×)	48.9×	66.7×	124.2×	15.7×	18.4×	↓ trend
Return on equity (%)	—	11.2	16.4	12.0	12.5	↑ trend
Goodwill as % assets (%)	16.6	15.6	12.9	20.0	20.5	↑ trend
Intangibles as % assets (%)	13.8	12.1	8.6	15.6	13.7	flat
DSO (d)	110d	112d	135d	95d	94d	↓ trend

S1_001	▶ inorganic revenue opacity Revenue growth of 18.0 millions in FY2025 coincided with a 60% increase in goodwill and amortization of acquired intangible assets totalling £8.4m, consistent with the consolidation of an acquired entity during the period; however, the notes do not disclose the consolidation date, the partial-year contribution from the acquired entity, or the organic revenue attributable to the acquisition, making the organic growth rate not determinable from the reported revenue series alone.
Why it matters The reported revenue growth may include a partial-year contribution from an acquired business, which could inflate or deflate the apparent organic growth rate. Without explicit management disclosure of organic or like-for-like growth, the underlying organic revenue trajectory cannot be assessed from the financial statements. Confirmed, corroborated and unaddressed hypotheses confirmed The notes provide segment revenue data (£361.0m in FY2025 vs. £342.7m in FY2024) but do not disclose organic growth, like-for-like growth, or any decomposition of organic versus inorganic revenue. The notes document a segment restatement but do not provide the organic/inorganic split necessary to determine the underlying organic growth rate from the reported revenue series alone. This confirms the mechanism: the financial series is not decomposable without explicit management disclosure of organic or like-for-like growth, which is absent from the notes. “Previously, the Consumer Division was further split out into two operating segments: Children's Trade and Adult Trade. During the year, the Children's Trade and Adult Trade operating results have been combined into a single Consumer category for reporting regularly reviewed by the Chief Operating Decision Maker. Comparative information for prior periods has been restated to reflect this change.” Revenue and segmental analysis, 2024–2025 Annual Reports. corroborated The notes disclose amortization of acquired intangible assets of £(8.4)m in FY2025 and £(4.9)m in FY2024, evidencing that acquisitions occurred and intangible assets were recognized. This corroborates that an acquired entity was consolidated during the period. However, the notes do not disclose the consolidation date, the partial-year contribution from the acquired entity, or the revenue attributable to the acquisition. The mechanism (partial-year revenue contribution affecting growth rate) is implied by the presence of acquired intangibles but is not explicitly quantified or named in the notes. “Amortisation of acquired intangible assets: Consumer £(0.4)m, Academic & Professional £(7.7)m, Special Interest £(0.3)m, Non-Consumer £(8.0)m, Total £(8.4)m” Revenue and segmental analysis, 2024–2025 Annual Reports. contradicted The notes disclose amortization of acquired intangible assets totalling £(8.4)m in FY2025, evidencing that acquisitions with intangible assets (typically associated with revenue-generating businesses or customer relationships) occurred during the period. This directly contradicts the claim that the goodwill step-up reflects "an asset acquisition without a revenue-generating business being transferred" or that "no acquired revenue is consolidated." The presence of acquired intangible assets being amortized indicates that revenue-generating assets or intangible assets with economic value were acquired and consolidated. “Amortisation of acquired intangible assets: Consumer £(0.4)m, Academic & Professional £(7.7)m, Special Interest £(0.3)m, Non-Consumer £(8.0)m, Total £(8.4)m” Revenue and segmental analysis, 2024–2025 Annual Reports.
S1_002	▶ revenue growth deceleration Revenue declined 9.7% in FY2025→FY2026, materially below the 9.1% multi-year CAGR; this deceleration is consistent with a mechanical base effect, as the notes disclose a material structural reclassification in which Special Interest was moved from the Non-Consumer Division into the Consumer Division during the period, with the Consumer Division's reported revenue declining by £59.5m and Academic & Professional increasing by £24.4m following the restructuring.
Why it matters The reported revenue decline may reflect the reclassification of segments rather than organic demand deterioration. However, the notes do not quantify the impact of the reclassification on the reported revenue movements, leaving the extent to which the decline is mechanical versus organic unresolved. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose a material structural change: Special Interest was reclassified from the Non-Consumer Division into the Consumer Division during the period, with comparative information restated. This reclassification is a mechanical, non-organic event that directly affects reported segment revenue. The Consumer Division's revenue declined from £277.7m to £218.2m (£59.5m decrease), while Academic & Professional increased from £83.3m to £107.7m (£24.4m increase). The segment restructuring is a disclosed structural change that is mechanically relevant to explaining segment-level revenue movements, consistent with a base-effect or reclassification mechanism. However, the notes do not quantify the impact of the reclassification on the reported revenue decline, and do not explicitly attribute the decline to this change. The mechanism is corroborated by the disclosed restructuring but not confirmed with quantified attribution. “During the period, the operational structure of the Group was changed and Special Interest is now part of the Consumer Division.” Revenue and segmental analysis, 2025–2026 Annual Reports. unaddressed The notes provide segment revenue data showing Consumer revenue declined from £277.7m to £218.2m and Academic & Professional revenue increased from £83.3m to £107.7m, but do not address market saturation, demand normalisation, or penetration rates. The notes do not explain whether the revenue deceleration reflects market dynamics or structural changes. No disclosure of addressable market size, customer acquisition trends, or saturation indicators is provided. unaddressed The notes do not disclose any exit from revenue streams, portfolio pruning, or strategic rebalancing. The segment data shows Consumer revenue declining and Academic & Professional revenue increasing, but the notes do not characterise this movement as deliberate pruning or quality improvement. No disclosure of margin profiles by segment, exit decisions, or strategic rebalancing is provided in the revenue note.

S2_001	▶ recurring exceptional items Exceptional items classified as integration and restructuring costs recurred in 2 of 5 years (FY2025 and FY2026), with the same acquisition (Rowman & Littlefield) generating charges across consecutive periods and prior acquisitions (ABC-CLIO, Head of Zeus) each producing similar costs, establishing a pattern of serial acquisition integration generating recurring exceptional charges without a single underlying triggering event.
Why it matters The recurrence of acquisition-related exceptional charges across multiple years and multiple acquisitions raises the question of whether these costs reflect the operational character of the Group's acquisition-led growth strategy rather than non-recurring events, though the appropriateness of exceptional classification remains subject to management intent and auditor assessment. Confirmed, corroborated and unaddressed hypotheses confirmed The notes explicitly disclose acquisition-related costs in consecutive years: FY2026 integration and restructuring costs £1.7m (Rowman & Littlefield); FY2025 legal and professional fees £0.7m and integration and restructuring costs £0.5m (Rowman & Littlefield); FY2024 legal and professional fees £0.7m and integration and restructuring costs £1.7m (ABC-CLIO and Head of Zeus). The mechanism of serial acquisition integration generating recurring exceptional charges is directly named and quantified. The same acquisition (Rowman & Littlefield) appears in both FY2026 and FY2025, and prior acquisitions (ABC-CLIO, Head of Zeus) generated costs in FY2024, establishing a pattern of successive acquisitions each producing integration costs classified as highlighted items. “For the year ended 28 February 2026, integration and restructuring costs of £1.7m were incurred in respect of the integration of the Rowman & Littlefield acquisition, the UK distributor move to Hachette UK Distribution and the implementation of the new royalty system.” Operating profit, 2025–2026 Annual Reports. unaddressed The notes disclose integration and restructuring costs tied to specific acquisitions (Rowman & Littlefield in FY2026 and FY2025; ABC-CLIO and Head of Zeus in FY2024) rather than a single multi-year transformation programme. The notes do not describe an ongoing, unified restructuring initiative spanning multiple years. Integration and restructuring costs vary year-to-year (£1.7m, £0.5m, £1.7m) and are attributed to discrete acquisition events, not a continuous programme. The mechanism of a genuinely recurring transformation programme is not addressed. unaddressed The notes state that highlighted items comprise "significant non-cash charges and major one-off initiatives" and frame them as items whose separate disclosure is "helpful in understanding the underlying performance and future profitability of the business." However, the notes do not explicitly address whether costs with an ongoing operational character (e.g., staff restructuring, system implementation) are being labelled exceptional to remove them from normalised earnings. The notes do not discuss management's classification rationale beyond the stated purpose of separate disclosure. The mechanism of operational costs being reclassified as exceptional annually is not directly addressed in the notes. unaddressed The notes disclose that the same acquisition (Rowman & Littlefield) generated costs in both FY2026 and FY2025, and that prior acquisitions (ABC-CLIO and Head of Zeus) generated costs in FY2024. This pattern indicates related causes across years rather than independent unrelated events. However, the notes do not explicitly state that the items are not independent or that they will recur together. The notes simply disclose the acquisitions and their associated costs. The mechanism of independent non-recurring events is weakened by the disclosed pattern but not directly contradicted or ruled out by an explicit management statement.
S2_002	▶ gross margin trajectory Gross margin improved 586 basis points from 53.0% to 58.9% over FY2022–FY2026, consistent with an inorganic mix shift in which Special Interest was restructured from the Non-Consumer Division to the Consumer Division; however, the notes do not separately disclose the gross margin of Special Interest or quantify its contribution to the blended margin improvement.
Why it matters While the segment restructuring is confirmed as occurring, the absence of granular margin disclosure for Special Interest leaves the extent to which this inorganic mix shift explains the long-term margin trajectory as an open question, and does not establish whether organic per-unit economics have improved materially. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose a structural change in which Special Interest was moved from the Non-Consumer Division (Academic & Professional) to the Consumer Division, with comparative information restated. This is an inorganic mix shift at the segment level. However, the notes do not disclose the gross margin of Special Interest separately or quantify its contribution to the blended margin change. The restructuring is confirmed as occurring, but the notes do not provide sufficient detail to isolate its impact on the margin improvement or to confirm that this structural change alone explains the long-term margin trajectory. The mechanism (inorganic mix shift via segment restructuring) is referenced but not quantified at the analytical level of the finding. “During the period, the operational structure of the Group was changed and Special Interest is now part of the Consumer Division.” Revenue and segmental analysis, 2025–2026 Annual Reports. unaddressed The notes disclose a significant shift in revenue mix toward the Consumer segment (lower gross margin at 52.2%) and away from Academic & Professional (higher gross margin at 70.8%), with Consumer revenue growing from £218.2m to £277.7m and Academic & Professional declining from £107.7m to £83.3m. However, the notes do not disclose pricing actions, discounting reductions, or product/customer mix shifts within segments. The segment restructuring (Special Interest moved to Consumer) is disclosed but is a structural reclassification, not evidence of pricing power or organic mix improvement. No narrative or quantified disclosure addresses pricing or within-segment mix dynamics. unaddressed The notes disclose cost of sales in aggregate (£(134.3)m in FY2024, £(157.1)m in FY2025) but provide no breakdown of raw material, supplier, or logistics costs. No disclosure addresses input cost reductions, supply chain improvements, or cost-side drivers of margin expansion. The notes do not quantify or reference any cost reduction mechanism.
S2_003	▶ sga ratio expansion SG&A as a percentage of revenue expanded 446 basis points from 42.2% to 46.6% over FY2022–FY2026, with FY2026 marking the series high; acquisition integration overhead of £1.7m in FY2026 (integration and restructuring costs for Rowman & Littlefield, distributor relocation, and royalty system implementation) is explicitly disclosed as part of administrative expenses and directly contributes to the SG&A expansion.
Why it matters The acquisition integration overhead is a confirmed driver of SG&A expansion in FY2026; if integration synergies and rationalisation of duplicate functions are realised in subsequent periods, the SG&A ratio may contract, though the timing and magnitude of such benefits remain uncertain. Confirmed, corroborated and unaddressed hypotheses confirmed Note 4 explicitly names acquisition integration overhead and quantifies it at £1.7m for FY2026. The note further states "All highlighted items are included in administrative expenses in the income statement," confirming that integration costs are part of the SG&A (administrative expenses) line. This directly evidences the acquisition integration overhead mechanism as a contributor to SG&A expansion in FY2026. The mechanism is named at the analytical level of the finding and quantified. “For the year ended 28 February 2026, integration and restructuring costs of £1.7m were incurred in respect of the integration of the Rowman & Littlefield acquisition, the UK distributor move to Hachette UK Distribution and the implementation of the new royalty system.” Operating profit; Staff costs, 2025–2026 Annual Reports. unaddressed The notes disclose headcount expansion (Editorial, production and selling rose from 967 to 1,033; Finance and administration rose from 194 to 205; total headcount increased from 1,161 to 1,238) despite flat staff costs (£78.8m to £77.5m), which is consistent with investment in sales capacity. However, the notes do not explicitly state that this investment is "ahead of revenue" or that it is part of an intentional investment cycle designed to normalise the ratio as revenue catches up. The headcount data is observable but the forward-looking investment rationale is not disclosed. The notes cover only FY2025–FY2026 and do not address the full 4-year trend (FY2022–FY2026) underlying the 446bps expansion. unaddressed The notes do not address whether administrative and selling costs have grown faster than revenue or whether there is structural cost drift without investment rationale. Staff costs declined modestly (£78.8m to £77.5m) while headcount increased 6.6%, suggesting cost efficiency rather than creep, but this is inference from data patterns, not explicit management disclosure of cost trajectory or operating leverage. The notes do not provide revenue figures or a full SG&A cost breakdown, so the ratio expansion mechanism cannot be directly assessed. The notes cover only FY2025–FY2026 and do not address the full 4-year trend. unaddressed The notes do not provide revenue figures for FY2025 or FY2026, so the denominator movement cannot be assessed from the supplied notes. Without revenue data, it is impossible to determine whether the SG&A ratio expansion reflects absolute cost growth, revenue decline, or a combination. The mechanism is unaddressed by the available disclosures.

S3_001	▶ receivables revenue divergence Trade receivables grew 56.8% year-over-year while revenue expanded 29.9%, a divergence explained by deterioration in cash collection efficiency — days sales outstanding expanded from 96 to 120 days, a 25% increase representing a material slowdown in the rate at which invoices convert to cash. The loss allowance increase and management's explicit disclosure of the DSO expansion confirm that customers are paying more slowly as the invoice base accumulates faster than cash is received.
Why it matters The confirmed collection slowdown indicates that working capital absorption will persist as long as DSO remains elevated at 120 days, creating an ongoing cash conversion headwind that offsets a portion of profit growth. Confirmed, corroborated and unaddressed hypotheses confirmed The notes explicitly disclose DSO expansion from 96 to 120 days, a 24-day increase representing a 25% deterioration in collection efficiency. This directly names and quantifies the mechanism of cash collection slowdown. The loss allowance movement (increase from £3,334k to £3,617k with "Amounts created: 29 February 2024 £1,259k") corroborates management's recognition of increased credit risk associated with slower collections. The gross trade receivables grew from £72,549k to £115,607k (59.4% growth) while DSO expanded, indicating invoices are accumulating faster than cash is received — the core mechanism of collection deterioration. “The average number of days' credit taken for sales of books by the Group was 120 days (2023: 96 days).” Trade and other receivables, 2023–2024 Annual Reports. unaddressed The notes do not disclose any shift in contractual payment terms, enterprise contract mix, or term extensions (e.g., "net-60 or net-90 terms offered"). The DSO disclosure shows deterioration but does not attribute it to a contractual mix shift toward longer-term contracts. The mechanism of "revenue mix shift toward enterprise contracts with longer contractual payment terms" is not addressed in the notes. The DSO expansion could reflect slower payment by existing customers under unchanged terms, or it could reflect a mix shift — the notes do not distinguish. Without explicit disclosure of term changes or enterprise contract growth, this mechanism remains unaddressed. </rationale> unaddressed The notes do not address revenue timing, Q4 concentration, seasonal patterns, or the proportion of annual invoices unpaid at the balance sheet date. No disclosure discusses the timing of revenue recognition within the fiscal year or back-end loading of sales. The mechanism of Q4 back-end revenue concentration is not referenced in the receivables notes.
S3_002	▶ dso elevated or deteriorating Elevated receivables and working capital outflow in FY2024 reflect structural business model characteristics and revenue growth dynamics rather than collection deterioration. The receivables base includes £36.4m in royalty advances and £10.0m in contract assets on long-term rights deals — components inherent to the publishing business model — which explain why total receivables appear elevated. Simultaneously, the material £54.4m increase in receivables in FY2024 is consistent with revenue growth absorbing working capital as the business scales, a pattern corroborated by the step-change in receivables movement relative to FY2023 (£3.2m). Management's own DSO calculation of 79 days in FY2026 and 80 days in FY2025, both below the 90-day threshold, and the decline in gross receivables from £82.1m to £72.9m in the most recent year, indicate that collection efficiency has not deteriorated on a forward basis. The increase in trade and other liabilities of £43.9m in FY2024 further offset the receivables build, providing a partial cash benefit that mitigated the working capital drag.
Why it matters The working capital outflow in FY2024 represents a transient scaling cost associated with revenue growth and the structural shape of the publishing business model, rather than a signal of deteriorating credit quality or collection performance. As the business matures and revenue growth moderates, working capital absorption should normalize. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose structural receivables components that are inherent to the publishing business model: royalty advances of £36.4m (28% of total receivables), contract assets of £9.5m current and £0.5m non-current, and the statement that "Non-current receivables relate to contract assets on long-term rights deals." These structural features — advance payments for publishing rights and long-term contract assets — explain why total receivables are elevated and why DSO calculated on total receivables (rather than trade receivables alone) may appear elevated. The notes also disclose that £13.0m of royalty advances relate to titles expected to be published in more than 12 months' time, confirming a structural business model feature. This corroborates that elevated receivables reflect structural industry and business model characteristics rather than collection deterioration. However, the notes do not explicitly characterize DSO as normal for the sector, so corroboration is partial. “Non-current receivables relate to contract assets on long-term rights deals.” Trade and other receivables, 2025–2026 Annual Reports. contradicted The notes disclose management's own DSO calculation as 79 days in FY2026 and 80 days in FY2025, both materially below the 90-day threshold and the finding's reported range of 94–135 days. Additionally, gross trade receivables declined from £82.1m (FY2025) to £72.9m (FY2026), and net trade receivables declined from £79.4m to £70.7m, inconsistent with collection efficiency deterioration. Loss allowance decreased from £2.7m (FY2025) to £2.2m (FY2026) as a proportion of gross receivables, and the notes state "The majority of trade debtors are secured by credit insurance," indicating active credit risk mitigation rather than deterioration. “The average number of days' credit taken for sales of books by the Group was 79 days (2025: 80 days).” Trade and other receivables, 2025–2026 Annual Reports. unaddressed The notes do not disclose revenue by quarter, half-year, or period-end concentration. No revenue timing data is provided. However, the notes' disclosed DSO of 79–80 days is management's own metric and would inherently reflect any period-end revenue concentration in the calculation. The contradiction between the finding's 94–135 day range and the notes' 79–80 day figure suggests either a different DSO calculation methodology or a factual discrepancy, but the notes do not address revenue timing as a driver of DSO. unaddressed The notes do not disclose customer payment terms, customer mix composition, or any shift toward longer contractual terms. The notes reference "average number of days' credit taken" (79 days) but do not explain whether this reflects standard terms, extended terms, or a mix. No disclosure of customer segmentation or term changes is provided.
S3_003	▶ ocf ni ratio step change The compression of the OCF/NI ratio from 2.35× to 1.35× between FY2022 and FY2023 reflects a material working capital swing rather than a change in earnings quality. Inventory build accelerated from £2.7m to £7.6m, receivables swung from a £1.2m inflow to a £3.2m outflow, and payables growth decelerated from £14.6m to £4.0m — a combined adverse movement across three working capital components. Simultaneously, profit increased from £16.9m to £20.2m, creating a divergence in which operating cash flow declined while net income rose, directly explaining the ratio compression.
Why it matters The step-change in the OCF/NI ratio is a timing artefact driven by lumpy working capital movements in a single year, not an indicator of deteriorating earnings quality or cash generation capability. Confirmed, corroborated and unaddressed hypotheses corroborated The cash flow statement discloses a material working capital deterioration in FY2023. Inventory build increased significantly from £(2,745)k to £(7,557)k. Trade and other receivables swung from a £1,205k inflow to a £(3,226)k outflow, representing a material adverse movement. Trade and other liabilities growth declined substantially from £14,572k to £4,033)k, a significant reduction in inflow. These three movements combined represent a material additional operating cash flow headwind in FY2023 vs. FY2022. Simultaneously, profit for the year increased from £16,890k to £20,244k. This divergence — operating cash flow declining while profit rose — directly explains the ratio compression. The mechanism is corroborated by the disclosed data pattern across multiple working capital line items. “(Increase) in inventories: Year ended 28 February 2023 £(7,557)k, Year ended 28 February 2022 £(2,745)k” Consolidated Statement of Cash Flows; Other intangible assets, 2022–2023 Annual Reports. unaddressed While amortisation of other intangible assets increased from £7,505k to £9,687k, this non-cash addback would mechanically elevate OCF/NI, not compress it. The observed ratio compression (2.35× to 1.35×) is inconsistent with a D&A step-change mechanism, which would move the ratio in the opposite direction. The notes do not address why the ratio compressed despite higher amortisation. unaddressed The cash flow statement and notes contain no disclosure of impairment charges, restructuring costs, or other non-cash/non-recurring charges in FY2023. No line item in the cash flow statement or note disclosure references such a charge. This mechanism is not addressed in the financial statements. unaddressed The notes disclose finance income of £(270)k (FY2023) and share of loss of joint venture of £228k (FY2023), neither of which represents a material non-cash income item. No fair value gains, deferred revenue releases, or other significant non-cash income items are disclosed. The magnitude of these items is insufficient to explain the 1.00× compression in the OCF/NI ratio.
S3_004	▶ payables compression Trade payables declined from £48m to £30m over FY2024–FY2026, a material compression that could reflect deliberate early payment policy, a structural shift toward suppliers with shorter standard payment terms, or reduced purchasing volume. The available financial data does not distinguish among these mechanisms — procurement terms, days payable outstanding, and purchasing volume trends are required to identify the driver.
Why it matters If the compression reflects deliberate early payment or term shortening, it represents a strategic working capital choice that may improve supplier relationships but will reduce the cash benefit from payables. If it reflects reduced purchasing volume, it may signal a contraction in the input cost base. The mechanism remains unresolved and should be clarified through management commentary or detailed procurement data. Why this is open Zero supported candidates. All three mechanisms (deliberate early payment policy, supplier mix shift toward shorter terms, reduced purchasing volume) are unaddressed in the notes. The notes disclose standard payment terms of 30–90 days but provide no evidence of deliberate early payment, supplier composition changes, or purchasing volume trends. The absolute decline in trade payables from £48m to £30m is factual, but the mechanism driving the decline cannot be ranked from available evidence. No companion tension in this section measures a related metric (e.g., DPO deterioration, procurement cost trends) that would allow consolidation. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes disclose standard payment terms of 30–90 days but do not reference any deliberate early payment policy, settlement discount programme, or strategic payment acceleration initiative. Disclosure of standard terms does not corroborate a non-standard early-payment practice. No quantification of payment timing, discount capture, or supplier relationship investment is provided. The mechanism remains unaddressed. unaddressed The notes do not disclose supplier composition, procurement category mix, geographic sourcing changes, or any structural shift in the supplier base. No reference to changes in supplier types, product categories, or sourcing strategy is made. The standard-terms policy statement does not address whether the mix of suppliers or their payment terms has changed. The mechanism remains unaddressed. unaddressed The notes do not disclose purchasing volume, cost of goods sold, input cost trends, or any metric that would evidence whether payables decline tracks a contraction in purchasing activity. While trade payables fell from £48.1m to £29.8m across the two-year period, the notes provide no purchasing or cost-of-sales data to establish whether this decline is proportional to a volume reduction or driven by other factors. The mechanism remains unaddressed.
S3_005	▶ ocf fcf variability Operating cash flow variability over FY2022–FY2026 (ranging 27.0–42.0m, a 35.7% peak-to-trough swing) is driven by two confirmed, non-recurring mechanisms: lumpy working capital movements and acquisition-year cash costs. Receivables contributed £32.8m to operating cash flow in FY2025 but only £0.3m in FY2026, a material swing. Inventory reversed from a £7.8m outflow in FY2025 to a £5.6m inflow in FY2026. Additionally, the FY2025 trough in operating cash flow coincided with a £64.8m acquisition outflow and £29.4m in acquisition financing, with investing cash flows falling from £69.9m in FY2025 to £8.2m in FY2026 as the deal-related costs were non-recurring.
Why it matters The non-monotonic OCF pattern reflects episodic, non-recurring events — working capital timing reversals and a single acquisition — rather than structural deterioration in underlying cash generation. The variability should moderate as these timing effects normalize over the medium term. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly disclose a material swing in receivables working capital benefit from £32.8m inflow in FY2025 to £0.3m in FY2026 — a significant deterioration in working capital contribution to OCF. This is a direct, quantified disclosure of lumpy receivables movement. Additionally, inventory swung from £(7.8)m outflow in FY2025 to £5.6m inflow in FY2026, representing a substantial reversal. These working capital movements are named and quantified at the analytical level of the finding and directly explain the non-monotonic OCF pattern between the two years. “Decrease in trade and other receivables: Year ended 28 February 2026 £0.3m, Year ended 28 February 2025 £32.8m” Consolidated Statement of Cash Flows, 2025–2026 Annual Reports. confirmed Notes explicitly disclose a non-recurring acquisition outflow of £(64.8)m in FY2025, with supporting evidence of acquisition financing (Proceeds from borrowings: Year ended 28 February 2025 £29.4m). The investing cash outflow in FY2025 was £(69.9)m, driven substantially by this deal. In FY2026, investing outflows fell to £(8.2)m, representing a significant step-down consistent with the non-recurring nature of the acquisition. The mechanism is explicitly named and quantified, and the step-change in investing cash flows directly reflects the episodic nature of the acquisition cost. “Purchase of business, net of cash acquired: Year ended 28 February 2025 £(64.8)m” Consolidated Statement of Cash Flows, 2025–2026 Annual Reports. unaddressed Notes disclose modest and stable capex: Purchase of property, plant and equipment of £(1.4)m in both FY2026 and FY2025. Purchase of other intangible assets increased from £(4.8)m to £(7.5)m, but this is not a material driver of FCF compression relative to the £(64.8)m acquisition outflow in FY2025. The notes do not disclose a significant capex cycle, lumpy capital investment pattern, or material capital expenditure that would explain the observed OCF/FCF variability. Capex timing is not addressed as a material mechanism within the observed window.

S4_001	▶ debt liquidity movement Total debt increased 259.6% and cash declined 37.9% in FY2025, driven by acquisition financing for the Rowman & Littlefield business combination completed in May 2024 at a cash cost of £65m, with borrowing proceeds of £29.4m raised under a term loan facility and non-current borrowings of £23.6m outstanding at year-end. A capital return to shareholders through equity dividends of £12.2m was also funded from cash, but represents a substantially smaller use of cash than the acquisition outlay and is not the primary driver of the debt movement. The Group remained in compliance with all financial covenants at 28 February 2025, ruling out a leverage ratio breach driven by EBITDA decline as an explanatory mechanism.
Why it matters The debt increase reflects a deliberate financing decision to fund a material acquisition, with the company maintaining covenant headroom despite the elevated leverage. The disclosed pro-forma profitability of the acquired business (£25.4m profit if consolidated from 1 March 2024) indicates the acquisition is expected to generate earnings to support debt service and eventual deleveraging over time. Confirmed, corroborated and unaddressed hypotheses confirmed Note 10 explicitly names the Rowman & Littlefield acquisition completed 28 May 2024 with cash consideration of $83m (£65m). Note 10 states the loan was taken out to acquire Rowman & Littlefield. Note 19 discloses proceeds from borrowings of £29.4m in FY2025 and non-current borrowings of £23.6m at 28 February 2025 (versus nil at 29 February 2024). The mechanism is named at the analytical level of the finding with quantified figures: acquisition cost £65m, borrowing proceeds £29.4m, resulting debt balance £23.6m. This directly explains the significant debt growth. “This loss includes the interest expense to service the loan taken out to acquire Rowman & Littlefield, acquired intangible amortisation and other highlighted items.” Business Combinations; Borrowings; Share-based payments, 2024–2025 Annual Reports. corroborated Note 19 discloses equity dividend paid of £(12.2)m in FY2025. This represents a capital return to shareholders funded from cash. However, the dividend (£12.2m) is substantially smaller than the total debt increase (£29.4m proceeds from borrowings) and the acquisition cash outlay (£65m). The notes do not state that debt was raised specifically to fund the dividend; rather, the primary driver of borrowing is the acquisition. The dividend is a use of cash but not the primary mechanism explaining the 259.6% debt growth. Corroborated because the dividend is disclosed and represents a capital return, but unaddressed as the primary driver of the debt movement. “Equity dividend paid: Liability -, Liability -, Liability -, Equity -, Equity -, Equity (12.2), Total (12.2).” Business Combinations; Borrowings; Share-based payments, 2024–2025 Annual Reports. contradicted Note 19 explicitly states the Group "was in compliance with all covenants" as at 28 February 2025 and "believes that it will continue to comply with the covenants." This directly contradicts the mechanism that a leverage ratio breach driven by EBITDA decline occurred. If EBITDA had declined materially relative to debt, the Group would face covenant breach risk. The pro-forma disclosure ("If the acquisition had occurred on 1 March 2024...profit attributable to shareholders...£25.4m") indicates the acquired business is profitable and contributes to consolidated earnings. The explicit covenant compliance statement rules out the denominator compression / EBITDA decline mechanism as the driver of the observed debt-to-EBITDA movement. “As at the 28 February 2025, the Group was in compliance with all covenants.” Business Combinations; Borrowings; Share-based payments, 2024–2025 Annual Reports. unaddressed Note 19 shows proceeds from borrowings of £29.4m and repayment of borrowing of £(6.2)m in FY2025, but these are not presented as a refinancing of the same debt instrument. The repayment line appears to relate to existing facilities, not a gross refinancing of new debt. The notes do not disclose a refinancing transaction (issuance and repayment of the same debt tranche in the same period). Without explicit disclosure of a refinancing event, this mechanism remains unaddressed. unaddressed The notes do not indicate an operational cash shortfall. Note 22 states the Group "has moderate borrowing and has sufficient cash deposits to meet its debts as they fall due" and forecasts compliance with covenants under a severe downside scenario. The Rowman & Littlefield acquisition contributed £19.8m revenue and a £(0.8)m loss (which includes acquisition-related interest and amortisation, not an operational shortfall). No disclosure of operating losses, working capital deficits, or capital expenditure pressures that would necessitate debt drawdown for operational needs. The debt increase is explicitly linked to acquisition financing, not operational shortfall.
S4_002	▶ post acquisition asset trajectory Acquired intangible assets declined £10m (16.7%) in the first full year post-acquisition, with a reported amortisation charge of £3m, while goodwill declined £2.4m (2.6%) from £81.6m to £79.2m. The goodwill decline is attributable entirely to foreign exchange translation effects of £(2.4)m as the reporting currency strengthened against the acquisition currency, with no impairment charge recorded. Exchange differences on intangible assets (publishing rights £0.4m, product development £0.1m) confirm that FX translation effects are reducing the carrying values of acquired assets.
Why it matters The intangible asset decline reflects scheduled amortisation of finite-life publishing rights, imprints, and ebook/POD files rather than impairment or operational deterioration. The goodwill movement is a non-cash accounting adjustment driven by currency translation, not a signal of acquisition value erosion. Confirmed, corroborated and unaddressed hypotheses corroborated Note 11 explicitly discloses exchange differences of £(2.4)m for goodwill at 28 February 2026, which accounts for the entire goodwill decline from £81.6m to £79.2m. The note confirms that the goodwill reduction is attributable to FX translation as the reporting currency strengthened against the acquisition currency. Note 12 also shows exchange differences on intangibles (Publishing rights £0.4m, Product development £0.1m), confirming FX effects on acquired assets. The mechanism of FX translation reducing goodwill and intangible carrying values is corroborated by the disclosed exchange differences. “Exchange differences: 28 February 2026 £(2.4)m, 28 February 2025 £0.4m” Business Combinations; Goodwill; Other intangible assets, 2025–2026 Annual Reports. contradicted The notes explicitly state that goodwill is not amortised and is subject to annual impairment reviews, with any impairment losses recognised immediately in the income statement. The goodwill decline from £81.6m to £79.2m is attributed entirely to exchange differences of £(2.4)m, not impairment. The notes disclose no impairment charge for goodwill in the period. The value-in-use calculations show no impairment was identified. This directly contradicts the mechanism of goodwill impairment or partial write-down. “Goodwill is not amortised but instead, in accordance with IFRS, is subject to annual impairment reviews.” Business Combinations; Goodwill; Other intangible assets, 2025–2026 Annual Reports. unaddressed Note 12 discloses the gross carrying value of intangible assets and movements (acquisitions, additions, transfers, disposals, exchange differences) but does not disclose the amortisation or depreciation charge for the period. The finding references a £3m D&A charge, but this figure does not appear in the supplied note paragraphs. Without the amortisation expense disclosed in the notes, the mechanism of scheduled amortisation cannot be confirmed or corroborated from the supplied disclosures. The note shows asset movements but not the P&L charge that would evidence scheduled amortisation. unaddressed The notes do not disclose operating margins, margin trends, or evidence of improving operating performance coinciding with the intangible decline. While the notes mention that acquisitions are integrated into existing divisions and synergies are expected, no quantified evidence of synergy realisation or margin improvement is provided in the supplied note paragraphs. The mechanism of synergy delivery improving operating margins cannot be addressed from the disclosed information.
S4_003	▶ debt funded acquisition An investing cash outflow of £64m in FY2025 (17.7% of revenue) coincided with debt issuance of £21m in the same year, with debt proceeds covering approximately 33% of the acquisition outlay. The acquisition loan is classified as non-current borrowings of £23.6m under a term loan agreement with Lloyds Bank Plc, carrying long-term financial covenants (minimum interest cover, maximum net debt to EBITDA ratio). This structure is inconsistent with short-term bridge financing and is consistent with the mechanism of a permanent term loan facility raised specifically to fund the acquisition.
Why it matters The acquisition was financed through a combination of debt (£29.4m proceeds) and existing cash resources, establishing a permanent increase in the company's debt service obligations and covenant exposure for the term of the facility. The non-current classification and long-term covenant structure indicate this is not temporary bridge financing expected to be repaid within 12–24 months. Confirmed, corroborated and unaddressed hypotheses confirmed Note 10 explicitly names a loan taken out to acquire Rowman & Littlefield. Note 19 discloses proceeds from borrowings of £29.4m in FY2025 (the acquisition year) and confirms non-current borrowings of £23.6m at 28 February 2025 under a loan agreement with Lloyds Bank Plc with financial covenants (minimum interest cover, maximum net debt to EBITDA ratio). The non-current classification and long-term covenant structure confirm this is a term loan, not temporary financing. The mechanism of permanent leverage addition is confirmed by the explicit disclosure of the loan purpose (acquisition), the debt proceeds in the acquisition year, and the non-current balance sheet classification with long-term financial covenants. “This loss includes the interest expense to service the loan taken out to acquire Rowman & Littlefield, acquired intangible amortisation and other highlighted items.” Business Combinations; Borrowings; Share-based payments, 2024–2025 Annual Reports. contradicted The notes classify the acquisition loan as non-current borrowings with financial covenants (minimum interest cover, maximum net debt to EBITDA ratio). These covenants and the non-current classification are inconsistent with short-term bridge financing expected to be repaid within a short timeframe. Bridge facilities are typically short-term and do not carry long-term financial covenants. The covenant structure and balance sheet classification directly contradict the characterization of this as temporary bridge financing. “As at the 28 February 2025, the Group has non-current borrowings amounting to £23.6m under a loan agreement with Lloyds Bank Plc.” Business Combinations; Borrowings; Share-based payments, 2024–2025 Annual Reports. unaddressed The notes disclose total acquisition consideration of £65m (£60m on completion, £5m post-completion) and proceeds from borrowings of £29.4m in FY2025. However, the notes do not explicitly state the composition of funding sources — specifically, how much of the £65m consideration was funded from existing cash reserves versus new debt. The notes present the total consideration and debt proceeds as separate line items but do not address the mixed funding structure or confirm that the remaining £35.6m came from cash reserves. The mechanism of mixed financing (partial cash reserves, partial debt) is not addressed in the notes.
S4_004	▶ interest cost step change Interest expense grew 133.3% from FY2025 to FY2026, with the increase driven by a step-up in lease finance charges from £0.3m to £0.7m under IFRS 16 accounting for right-of-use assets. This increase occurred despite net repayment of bank borrowings of £7.4m in the same period, with interest on bank loans declining from £1.6m to £1.1m. Right-of-use asset additions of £7.5m were recognised on the balance sheet in FY2026, evidencing new leases recognised under IFRS 16.
Why it matters The interest expense growth reflects the accounting impact of new lease obligations recognised on the balance sheet rather than an increase in financial debt or borrowing costs. The simultaneous reduction in bank loan interest indicates that the company is actively managing its financial leverage while expanding its lease portfolio. Confirmed, corroborated and unaddressed hypotheses confirmed Note 6 explicitly discloses lease finance charges increasing from £0.3m to £0.7m, a 133.3% increase matching the finding precisely. Note 19 confirms "Right-of-use asset additions: Liability 7.5, Liability -, Liability -" in the 2026 period, evidencing new leases recognised on the balance sheet under IFRS 16. The mechanism is named at the analytical level (lease liabilities) and quantified with specific figures. “Interest on lease liabilities: Year ended 28 February 2026 £0.7m, Year ended 28 February 2025 £0.3m” Finance income and finance costs; Borrowings, 2025–2026 Annual Reports. contradicted Note 19 shows net repayment of borrowings of £(7.4)m in the 2026 period, and interest on bank loans declined from £1.6m to £1.1m. These movements contradict the mechanism of new debt raising. The notes explicitly record a cash outflow for debt repayment, not proceeds from new borrowing, and the interest charge on bank loans fell, not rose. “Repayment of borrowing: Liability -, Liability (7.4), Liability -, Total (7.4).” Finance income and finance costs; Borrowings, 2025–2026 Annual Reports. unaddressed The notes do not disclose interest rates, repricing events, refinancing activities, or rate changes. The movement in interest on bank loans (decline from £1.6m to £1.1m) is inconsistent with rate increases, but the notes contain no explicit statement about rate repricing or refinancing that would either confirm or contradict this mechanism.
S4_005	▶ roe compression Return on equity compressed from 16.4% in FY2024 to 12.0% in FY2025 (a decline of 4.4 percentage points), consistent with earnings deterioration on the balance sheet. Profit after tax declined materially from £32.3m in FY2024 to £25.4m in FY2025, a reduction of approximately £6.9m or 21.4%, directly evidencing the numerator component of ROE compression. The full mechanism—whether the equity base remained stable or grew during this period—remains unaddressed by the available disclosures.
Why it matters If the equity base remained stable or grew modestly, the earnings decline alone accounts for the observed ROE compression. The magnitude of the profit decline (21.4%) is material and consistent with the observed ROE decline, raising the question of whether operating performance headwinds or acquisition-related integration costs contributed to the earnings deterioration. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose profit after tax declined from £32.3m (FY2024) to £25.4m (FY2025), a material decline of approximately £6.9m or 21.4%. This directly evidences earnings deterioration, the numerator component of ROE compression. The notes do not disclose the equity base for either year, so the full mechanism (deterioration on stable or growing equity) cannot be fully confirmed. However, the earnings decline is explicitly quantified and material, corroborating the earnings deterioration component of the mechanism. The mechanism is partially evidenced by the disclosed earnings figures. “Profit after tax attributable to owners of the Company: Year ended 28 February 2025 25.4, Year ended 29 February 2024 32.3” Earnings per share; Share capital and other reserves, 2025–2026 Annual Reports. unaddressed The notes disclose weighted average shares increased from 81,212,654 (FY2024) to 81,420,330 (FY2025), a modest increase of 0.26%. However, the notes do not disclose whether acquisitions, equity-funded capital programmes, or material share issuances occurred in FY2025. The absence of disclosure of such transactions does not rule them out (per Error 2 guidance — default disclosures do not contradict non-standard variations). The notes are silent on the mechanism of equity dilution from acquisitions or capital programmes, and therefore unaddressed. unaddressed The notes do not disclose retained earnings balances, movements in retained earnings reserves, or the composition of equity changes between FY2024 and FY2025. Note 21 describes the retained earnings reserve conceptually ("comprises profit for the year attributable to owners of the Company and other items recognised directly through equity") but provides no quantified movement or balance data. Without disclosed figures on retained earnings accumulation or equity base growth, the mechanism is unaddressed.
S4_006	▶ current ratio decline The current ratio declined for two consecutive years from 1.8087x in FY2023 to 1.6176x in FY2025, consistent with deliberate working capital optimisation rather than liquidity deterioration. Days' credit outstanding improved from 120 days to 80 days, with net trade receivables declining from £112.0m to £79.4m, evidencing faster cash conversion and improved asset turns. Current liabilities also declined from £152.0m to £133.0m, with trade payables falling from £48.1m to £36.4m and accruals declining from £67.2m to £58.7m. The company maintains non-current borrowings only, with no short-maturity debt facilities or commercial paper disclosed, ruling out short-term debt accumulation as a driver of the ratio decline.
Why it matters The current ratio decline reflects operational efficiency improvements in working capital management rather than a deterioration in liquidity position. The company's ability to reduce both receivables and payables while maintaining a current ratio above 1.6x indicates effective cash conversion and sufficient liquidity to meet near-term obligations. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose a material improvement in receivables collection efficiency, with days' credit declining from 120 days to 80 days. This directly evidences deliberate working capital optimisation through faster cash conversion. Net trade receivables fell from £112.0m to £79.4m, consistent with improved asset turns rather than operational deterioration. The pattern of declining receivables coupled with faster collection speed corroborates the working capital optimisation mechanism. “The average number of days' credit taken for sales of books by the Group was 80 days (2024: 120 days).” Trade and other receivables; Trade and other liabilities; Borrowings; Share-based payments, 2024–2025 Annual Reports. contradicted The notes disclose that borrowings are non-current (long-term) and moderate in amount. No current borrowings, commercial paper, or short-maturity debt facilities are disclosed. Current liabilities declined from £152.0m to £133.0m, with trade payables falling from £48.1m to £36.4m and accruals declining from £67.2m to £58.7m. The notes explicitly state "Currently, the Group has moderate borrowing and has sufficient cash deposits to meet its debts as they fall due." This directly contradicts the mechanism of short-term debt accumulation driving the current ratio decline. “As at 28 February 2025, the Group has non-current borrowings amounting to £23.6m under a loan agreement with Lloyds Bank Plc.” Trade and other receivables; Trade and other liabilities; Borrowings; Share-based payments, 2024–2025 Annual Reports. unaddressed While current assets declined (receivables from £164.8m to £133.3m) and current liabilities also declined (from £152.0m to £133.0m), the notes do not address whether this represents genuine liquidity compression or buffer erosion. The receivables decline is explained by improved collection efficiency (80 vs. 120 days), which suggests operational strength rather than compression. However, the notes do not provide forward-looking liquidity assessment, cash position disclosure, or analysis of whether the business is approaching liquidity stress. The notes state the Group "has sufficient cash deposits to meet its debts as they fall due," but this is a general statement without quantified cash balances or liquidity headroom analysis. The mechanism of "approaching 1.0x and potential refinancing pressure" is not addressed in the notes.
S4_007	▶ interest coverage basis divergence Cash interest paid and income statement interest expense diverged materially in FY2025, with the two measures substantially different. However, the notes explicitly disclose lease interest as a component of income statement interest expense (£0.3m in FY2025), and the cash flow reconciliation consistent with the view that lease interest is included in both the cash paid and the accrual-based interest charge. This treatment directly contradicts the mechanism that lease interest is excluded from the income statement figure, ruling out lease accounting reclassification as an explanation for the divergence. The underlying driver of the cash-to-accrual divergence remains unaddressed by the available disclosures.
Why it matters If lease interest is properly included in both the cash and income statement measures, the divergence must reflect other timing or accrual differences (such as accrued but unpaid interest, or non-cash interest charges). The income statement interest coverage ratio may not accurately represent the cash cost of debt service in this period, and cash-based interest coverage should be considered alongside accrual-based metrics. Why this is open IFRS 16 lease interest reclassification mechanism is contradicted by explicit note disclosure that lease interest (£0.3m) is included in both the cash paid and the income statement interest expense total (£2.1m). This rules out the mechanism that lease interest is excluded from the IS-based figure. Capitalised interest, PIK/accrued-but-unpaid interest, and EIR vs payment date divergence are all unaddressed — the notes show cash interest paid (£2.1m) equal to IS interest expense (£2.1m) in FY2025 with no disclosure of capitalisation, PIK arrangements, or EIR methodology. NV12 mismatch (contradicted status with affirming rationale on lease interest) does not affect the validity of the contradiction — the notes explicitly confirm lease interest is included in the IS charge, ruling out the proposed mechanism. The section cannot identify which mechanism explains the divergence in other years or periods. Confirmed, corroborated and unaddressed hypotheses contradicted The notes explicitly disclose lease interest as a component of income statement interest expense (Note 6), and the reconciliation in Note 19 confirms that lease interest of £0.3m is included in both the cash paid and the interest expense accrual. This directly contradicts the mechanism that lease interest is excluded from the IS-based figure. Under IFRS 16, lease interest flows through the income statement and is included in the IS interest charge; the notes confirm this treatment. The mechanism (lease interest being excluded from IS, causing cash interest to exceed IS interest) is ruled out by the explicit inclusion of lease interest in the disclosed IS interest expense total. “Interest on lease liabilities: Year ended 28 February 2025 £0.3m, Year ended 29 February 2024 £0.3m” Finance income and finance costs; Borrowings, 2024–2025 Annual Reports. unaddressed The notes disclose interest on bank loans of £1.6m and total interest expense of £2.1m for FY2025, with no reference to capitalised borrowing costs, qualifying assets under construction, or any adjustment for capitalisation to the balance sheet. The interest expense note lists only three categories (bank loans, lease liabilities, other interest payable) with no mention of a capitalisation mechanism. Capitalised interest is not addressed in the notes. unaddressed The notes show interest paid of £(2.1)m in the financing section of the cash flow reconciliation (Note 19) and interest expense of £2.1m in the income statement (Note 6), with the two figures being equal in FY2025. There is no disclosure of accrued interest, PIK arrangements, settlement of prior-year arrears, or any mechanism by which cash paid would exceed the current-year IS charge. If PIK or arrears settlement were occurring, the notes would disclose the accrual or the settlement; no such disclosure is present. This mechanism is unaddressed. unaddressed The notes do not disclose effective interest rate (EIR) calculations, step-up rates, front-loaded arrangement fees, or any systematic divergence between EIR-based recognition and contractual payment dates. The loan agreement with Lloyds Bank Plc is mentioned (£23.6m non-current borrowings as at 28 February 2025), but no interest rate structure, EIR methodology, or rate step-up is disclosed. The mechanism of EIR vs payment date divergence is unaddressed.
S4_008	▶ goodwill step up Goodwill increased by £29m from FY2024 to FY2025 (7.8% of the FY2024 asset base), accompanied by identifiable intangible assets of £35.3m comprising publishing rights (£29.2m, ten-year useful life), imprints (£2.5m, three to nine-year useful lives), and ebook/POD production files (£3.6m, three-year useful life). The goodwill of £28.6m is explicitly attributed to expected profitability and synergies from the Rowman & Littlefield acquisition, with identifiable net assets of £36.2m, implying an acquisition multiple of approximately 0.79x on net assets. The notes disclose pro-forma post-acquisition profitability (£25.4m profit if consolidated from 1 March 2024) and actual results for the partial-year period (£0.8m loss from 28 May 2024 to 28 February 2025). Goodwill is indefinite-life and subject to annual impairment testing, with accumulated impairment of £4.3m recorded at 28 February 2025, indicating that the balance sheet carries a concentration of indefinite-life assets exposed to impairment risk.
Why it matters The acquisition premium is embedded in both finite-life intangibles (subject to scheduled amortisation) and indefinite-life goodwill (subject to impairment testing). The disclosed pro-forma profitability suggests the acquisition is expected to generate returns sufficient to justify the premium, though the actual partial-year loss and accumulated impairment of £4.3m raise the question of whether the acquired business is delivering the expected synergies and profitability in the near term. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly disclose the identifiable intangible assets acquired (publishing rights £29.2m, imprints £2.5m, ebook/POD files £3.6m, total £35.3m) with stated finite useful lives. The mechanism — acquisition premium embedded in PPA intangibles with finite lives subject to amortisation — is named and quantified at the analytical level of the finding. The notes confirm these intangibles are included in Other intangible assets (Note 12). The disclosure of finite useful lives directly confirms the mechanism; amortisation charges going forward are an accounting consequence of the disclosed finite-life intangibles. “The publishing rights have a useful life of ten years, the imprints have useful lives ranging from three to nine years and the ebook and POD production files have a useful life of three years.” Business Combinations; Goodwill, 2024–2025 Annual Reports. confirmed Notes explicitly name the mechanism (expected profitability and synergies) and quantify the goodwill at £28.6m. The notes also provide identifiable net assets of £36.2m, allowing calculation of the acquisition multiple (goodwill of £28.6m on net assets of £36.2m, approximately 0.79x). The notes disclose pro-forma revenue and profit (£367.5m and £25.4m if acquisition had occurred 1 March 2024) and actual post-acquisition results (£19.8m revenue, £0.8m loss for the period from 28 May 2024). The mechanism is confirmed: the notes directly address the acquisition premium and its attribution to expected profitability and synergies. “The goodwill arising of £28.6m is attributable to the expected profitability of the acquired business and the synergies expected to arise after the acquisition.” Business Combinations; Goodwill, 2024–2025 Annual Reports. corroborated Notes explicitly disclose that goodwill (£81.6m gross, £77.3m net of accumulated impairment £4.3m at 28 February 2025) is indefinite-life and subject to annual impairment testing. The mechanism — goodwill concentration on the balance sheet as an indefinite-life asset subject to impairment — is named and the goodwill balance is quantified. However, the notes do not disclose total assets at 28 February 2025 or calculate the proportion of goodwill to total assets. The mechanism is corroborated by the disclosed goodwill balance and the explicit statement of indefinite-life status and impairment testing regime, but the concentration metric (proportion of total assets) is not quantified in the notes. “Goodwill is not amortised, but instead, in accordance with IFRS, is subject to annual impairment reviews.” Business Combinations; Goodwill, 2024–2025 Annual Reports. unaddressed The notes do not address tangible net asset position, tangible book value, or the impact of goodwill on leverage ratios and covenant headroom. While the notes disclose goodwill of £81.6m and identifiable net assets acquired of £36.2m, they do not calculate or disclose tangible net assets, tangible book value, or any metric that isolates the erosion of tangible assets caused by the goodwill step-up. The mechanism — goodwill inflating reported total assets and reducing tangible book value — is not addressed in the notes.

Key Tensions & Management Questions

Key Metrics

Financial Analysis

Important Notice

S5_001	▶ equity flow reversal Net equity outflows of £4m annually across FY2022–FY2026 are confirmed to reflect employee share scheme settlement and Employee Benefit Trust purchases rather than a directed capital return programme. Employee share option exercises (282,895 options in FY2026; 324,862 in FY2025) and EBT share acquisitions (holdings increased from £1.3m to £3.6m market value between FY2025 and FY2026) are structural features of the equity compensation design, with outflows driven by vesting schedules and scheme size rather than a discretionary buyback decision.
Why it matters The sustained negative equity cash flow does not represent a capital allocation choice to return cash to shareholders; it is a mechanical consequence of scheme administration. This distinction is material to assessing whether management is prioritising shareholder distributions or reinvestment, as the outflows are contractually embedded in compensation arrangements rather than discretionary. Confirmed, corroborated and unaddressed hypotheses confirmed The notes explicitly disclose employee share option exercises with quantified figures: (282,895) options exercised in FY2026 and (324,862) in FY2025. Note 22 further states "Awards are not exercisable after the vesting date and awards that vest on the vesting date are automatically exercised," confirming that scheme settlement is a function of scheme design and vesting schedules. The mechanism is named at the analytical level of the finding and quantified with specific exercise figures. “Exercised during the year: Year ended 28 February 2026 (282,895), Year ended 28 February 2025 (324,862)” Share capital and other reserves; Share-based payments, 2025–2026 Annual Reports. confirmed The notes explicitly name the EBT mechanism and its purpose: to acquire shares to satisfy share-based schemes. Note 21 provides quantified evidence of EBT share purchases: holdings increased from 212,935 shares (market value £1.3 million) at 28 February 2025 to 766,922 shares (market value £3.6 million) at 28 February 2026, representing a material increase in market value. This directly evidences the EBT purchase mechanism with specific figures at the analytical level of the finding. “The Employee Benefit Trust ('EBT') is an independent discretionary trust established to acquire issued shares of the Company to satisfy any of the share-based incentive schemes (see Note 22) and plans of the Company.” Share capital and other reserves; Share-based payments, 2025–2026 Annual Reports. unaddressed The notes contain no disclosure of a strategic capital allocation decision, a directed buyback programme, or a stated transition from growth funding to return-of-capital posture. The notes explicitly state "No shares are held by the Company as Treasury shares," which rules out a Company-directed buyback but does not directly rule out the business maturity narrative — it only indicates that if capital returns are occurring, they are not via the Company's own buyback mechanism. The maturity transition interpretation is not addressed in the notes.
S5_002	▶ debt funded acquisition The £64m investing outflow in FY2025 was financed through a term loan of £29.4m in proceeds, with £23.6m outstanding at year-end under a non-current facility with Lloyds Bank Plc. The non-current classification and long-term financial covenants (minimum interest cover, maximum net debt to EBITDA ratio) confirm this is permanent leverage addition rather than short-term bridge financing. The loan was explicitly raised to acquire Rowman & Littlefield and covers 33% of the acquisition outflow, with the remainder funded from existing cash and operating cash flow.
Why it matters The acquisition was financed through a structural increase in the company's debt service obligations and covenant exposure for the term of the facility. This capital allocation decision commits future cash flow to debt servicing and constrains financial flexibility, with implications for the company's ability to sustain concurrent capital claims (dividends, capex, equity compensation) without further borrowing or cash drawdown. Confirmed, corroborated and unaddressed hypotheses confirmed Note 10 explicitly names a loan taken out to acquire Rowman & Littlefield. Note 19 discloses proceeds from borrowings of £29.4m in FY2025 (the acquisition year) and confirms non-current borrowings of £23.6m at 28 February 2025 under a loan agreement with Lloyds Bank Plc with financial covenants (minimum interest cover, maximum net debt to EBITDA ratio). The non-current classification and long-term covenant structure confirm this is a term loan, not temporary financing. The mechanism of permanent leverage addition is confirmed by the explicit disclosure of the loan purpose (acquisition), the debt proceeds in the acquisition year, and the non-current balance sheet classification with long-term financial covenants. “This loss includes the interest expense to service the loan taken out to acquire Rowman & Littlefield, acquired intangible amortisation and other highlighted items.” Business Combinations; Borrowings; Share-based payments, 2024–2025 Annual Reports. contradicted The notes classify the acquisition loan as non-current borrowings with financial covenants (minimum interest cover, maximum net debt to EBITDA ratio). These covenants and the non-current classification are inconsistent with short-term bridge financing expected to be repaid within a short timeframe. Bridge facilities are typically short-term and do not carry long-term financial covenants. The covenant structure and balance sheet classification directly contradict the characterization of this as temporary bridge financing. “As at the 28 February 2025, the Group has non-current borrowings amounting to £23.6m under a loan agreement with Lloyds Bank Plc.” Business Combinations; Borrowings; Share-based payments, 2024–2025 Annual Reports. unaddressed The notes disclose total acquisition consideration of £65m (£60m on completion, £5m post-completion) and proceeds from borrowings of £29.4m in FY2025. However, the notes do not explicitly state the composition of funding sources — specifically, how much of the £65m consideration was funded from existing cash reserves versus new debt. The notes present the total consideration and debt proceeds as separate line items but do not address the mixed funding structure or confirm that the remaining £35.6m came from cash reserves. The mechanism of mixed financing (partial cash reserves, partial debt) is not addressed in the notes.
S5_003	▶ capital allocation competition Concurrent capital allocation claims (dividends, employee equity compensation, acquisition investment, and capex) collectively consumed 114% of operating cash flow in FY2022 and 189% in FY2025, consistent with compression of distributable surplus. This pattern is corroborated by profit decline from £32.3m to £25.4m (21.4% reduction) in FY2025, while aggregate capital claims remained elevated or increased (dividends maintained at £12.2m despite lower profit; acquisition of £64.8m; capex £6.2m). The company sustained these concurrent claims through net borrowing of £29.4m and a cash drawdown from £65.8m to £40.6m (37.4% reduction), indicating limited buffer for further earnings or operating cash flow deterioration without policy adjustment or additional debt.
Why it matters The breadth of concurrent capital claims leaves the company with constrained flexibility to absorb earnings or cash flow volatility. Any reduction in operating cash flow or increase in one capital claim would displace another without a policy change, raising the question of whether the current dividend level and acquisition-related debt service can be sustained if operating performance deteriorates further. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose profit decline from £32.3m to £25.4m (21.4% reduction), while OCF rose from £37.6m to £41.9m driven by working capital release (Decrease in trade and other receivables: £32.8m). Simultaneously, aggregate capital claims (dividends £12.2m, Employee Benefit Trust share purchases, acquisition of £64.8m, capex £6.2m) materially exceeded OCF, requiring net borrowing of £29.4m and a cash drawdown. The company maintained or increased shareholder distributions (dividends up from £11.3m) despite profit decline and a major acquisition. Cash fell from £65.8m to £40.6m (37.4% reduction). This data pattern directly evidences compression of distributable surplus: the company is sustaining concurrent capital claims despite profit deterioration and non-recurring working capital benefit, leaving limited buffer for further OCF or profit decline without policy adjustment or additional debt. “Profit for the year: Year ended 28 February 2025 £25.4m, Year ended 29 February 2024 £32.3m” Consolidated Statement of Cash Flows; Dividends; Business Combinations, 2024–2025 Annual Reports. unaddressed The notes disclose OCF of £41.9m but aggregate capital claims (dividends £12.2m, buybacks £3.8m, acquisition £64.8m, capex £6.2m) totalling £87.0m, requiring net borrowing of £23.2m and cash drawdown of £24.8m. The notes do not characterise OCF as "strong enough" to support all concurrent claims without incremental debt, nor do they provide management narrative that competition is managed within available cash. The reliance on debt and cash drawdown contradicts the premise that OCF alone supports all claims, but the notes do not explicitly address whether management views the concurrent claims as sustainable or stress-free. unaddressed Note 10 discloses the acquisition of the Rowman & Littlefield academic publishing business on 28 May 2024 as a discrete transaction, but does not characterise the timing as opportunistic or transient, nor does it state that capital claims will separate in subsequent periods. The notes show the acquisition occurred in FY2025 alongside ongoing dividends and buybacks, but provide no management narrative about whether this co-occurrence reflects opportunistic timing or sustained policy. The discreteness of the acquisition event does not establish that the co-occurrence is transient.
S5_004	▶ dividend per share movement Dividend per share increased from 0.11 in FY2022 to 0.12 in FY2023, but the mechanism driving this movement remains unaddressed. The increase may reflect earnings-led growth, a board commitment to progressive dividend policy independent of earnings, a change in share count from buybacks or issuances, or a one-time adjustment rather than an underlying policy shift.
Why it matters Without clarity on whether the DPS increase is supported by earnings growth, driven by policy, or affected by share count movements, the sustainability of the higher dividend level cannot be assessed. If the increase reflects policy rather than earnings growth, dividend cover may be compressing, particularly given the subsequent profit decline observed in FY2025. Why this is open DPS increased from 0.11 (FY2022) to 0.12 (FY2023), but no candidate classification is supported by note disclosure. All four candidates remain unaddressed: no notes provided on earnings trajectory, dividend policy, share count effects, or one-time adjustments. The tension is material to capital allocation character (dividend sustainability and policy signalling) but evidence does not rank mechanisms. The finding stands alone with no companion tension in this section measuring a related metric that would support the DPS movement. Confirmed, corroborated and unaddressed hypotheses unaddressed No note paragraphs provided. No disclosure of EPS, FCF per share, earnings growth, or management commentary on earnings trajectory is available to assess whether the DPS increase was supported by earnings-led growth. unaddressed No note paragraphs provided. No disclosure of dividend policy, board decisions, or progressive dividend commitments is available to assess whether the DPS increase reflects a policy-driven commitment independent of earnings. unaddressed No note paragraphs provided. No disclosure of share count changes, buyback activity, scrip dividend take-up, or share issuances is available to assess whether the DPS movement reflects a change in shares in issue rather than a change in total dividend declared. unaddressed No note paragraphs provided. No disclosure of special dividends, catch-up adjustments, period-length effects, or one-time items is available to assess whether the DPS change reflects a non-recurring adjustment rather than an underlying policy shift.